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While tuberculosis (TB) in Canadian cities is increasingly 
affecting foreign-born persons, homeless persons remain at 
high risk. To assess trends in TB, we studied all homeless 
persons in Toronto who had a diagnosis of active TB during 
1998–2007. We compared Canada-born and foreign-born 
homeless persons and assessed changes over time. We 
identiﬁ  ed 91 homeless persons with active TB; they typically 
had highly contagious, advanced disease, and 19% died 
within 12 months of diagnosis. The proportion of homeless 
persons who were foreign-born increased from 24% in 
1998–2002 to 39% in 2003–2007. Among foreign-born 
homeless persons with TB, 56% of infections were caused 
by strains not known to circulate among homeless persons 
in Toronto. Only 2% of infections were resistant to ﬁ  rst-line 
TB medications. The rise in foreign-born homeless persons 
with TB strains likely acquired overseas suggests that the 
risk for drug-resistant strains entering the homeless shelter 
system may be escalating.
I
n Canada’s major cities, tuberculosis (TB) is increasingly 
becoming a disease of persons born outside Canada 
(foreign-born). In 2009 in the city of Toronto in Ontario, 
94% of all persons with active TB were foreign-born 
(1). Although homeless and marginally housed persons 
represent a smaller proportion of TB case-patients, they 
remain a persistent high-risk population. Recent TB 
outbreaks and disease clusters among homeless persons 
have been reported in many cities in the United States (2–
5) and have been associated with transmission at shelters, 
single-room–occupancy hotels, and rooming houses 
(which provide inexpensive rooms with shared bathrooms), 
prisons, and bars (6–10).
Toronto is the largest city in Canada; among its 
population of 2.5 million persons, ≈50% were born outside 
Canada (11). Each year in Toronto, ≈29,000 persons use 
emergency shelters, and on any given night ≈5,000 are 
without homes (12). During 2001–2002, a large shelter-
based TB outbreak occurred among homeless persons in 
Toronto. A coroner’s inquest into the death of a homeless 
man in whom pulmonary TB developed during the course 
of this outbreak revealed the many challenges of diagnosing 
and managing TB in homeless populations (13). In response 
to the inquest and resulting jury recommendations, major 
changes to the management of homeless TB cases occurred 
in the public health and shelter systems, and local TB 
clinic capacity expanded. This case resulted in the creation 
of a public health team dedicated to case management, 
contact follow-up, advocacy, education, health promotion, 
and active case ﬁ  nding among the city’s homeless and 
underhoused population.
A comprehensive review of the population and 
molecular epidemiology, clinical features, management 
and health outcomes of homeless persons with TB in 
Canada is needed but lacking. To better understand and 
address the extent of disease in this vulnerable population, 
we studied TB among Toronto’s homeless persons over a 
10-year period.
Methods 
The study population included all persons in Toronto 
for whom active TB had been reported to Toronto Public 
Health from January 1, 1998, through December 31, 
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2007. Data were extracted from the Reportable Disease 
Information System and the Integrated Public Health 
Information System for all case-patients with a risk setting 
of “shelter/rooming house” or a risk factor of “homeless.” 
Health case management ﬁ   les were reviewed to ensure 
accuracy of database entries; additional data were abstracted 
when necessary. Cases were included in the analysis for 
persons with active TB who met the following eligibility 
criteria in the year before diagnosis: 1) any shelter stay, 2) 
any rooming house stay, 3) no ﬁ  xed address, or 4) use of 
services for homeless persons >1× per week. Cases were 
excluded for persons with active TB who 1) were foreign-
born and received a diagnosis of active TB within 1 month 
of arrival in Canada, 2) received a diagnosis of active TB 
while in a shelter designed exclusively for resettlement of 
newly arrived refugees, 3) were not residents of Toronto 
when they received a diagnosis of active TB, or 4) had 
incomplete records.
We collected data on patient demographics, clinical 
features of TB disease, medical management and health 
outcomes of patients, and molecular ﬁ  ngerprinting of the 
TB bacterium. Case types were classiﬁ   ed according to 
the Public Health Agency of Canada deﬁ  nition of new 
and re-treatment TB cases (14). All chest radiographs 
were interpreted by radiologists. Susceptibility testing for 
Mycobacterium tuberculosis was performed at the Central 
Public Health Laboratory of the Ontario Agency for Health 
Protection and Promotion. All isolates from new TB cases 
were tested for susceptibility to ﬁ  rst-line drugs (isoniazid, 
rifampin, pyrazinamide, and ethambutol) according to 
recommended standard protocols, by using the commercial 
broth system, BACTEC MGIT 960 (Becton, Dickinson and 
Company, Sparks, MD, USA). Isolates resistant to rifampin 
or any 2 ﬁ  rst-line drugs were also tested for susceptibility 
to second-line drugs (15). Restriction fragment-length 
polymorphism was performed for strain genotyping by 
using established methods (16). Genotypes were analyzed 
by using Bionumerics 5.0 (Applied Maths, Saint-Martens 
Latem, Belgium). HIV test results were recorded when 
available; information about use of antiretroviral therapy 
for HIV/TB–co-infected patients was not available. 
Comparisons were made between Canada-born and 
foreign-born case-patients and between 5-year periods 
(1998–2002 and 2003–2007) using the 2-sided Fisher 
exact test or χ2 test, as appropriate. Kaplan-Meier plots 
were generated to determine time to death from all causes 
during the 12 months after TB diagnosis. The log-rank test 
was used to compare survival curves between the 2 groups. 
Because of the small cohort size, multivariate regression 
analyses were not performed. All analyses were performed 
by using SAS version 9.1.3 (SAS Institute, Cary, NC, 
USA). Ethics approval was obtained from St. Michael’s 
Hospital Research Ethics Board.
Results
From January 1, 1998, through December 31, 2007, 
a total of 3,685 active TB cases were reported to Toronto 
Public Health; among these, 102 (2.8%) met the study 
inclusion criteria. Incomplete records for 11 patients 
resulted in a ﬁ  nal sample size of 91 (Figure 1). Most 
patients were absolutely homeless (i.e., living on the 
street or in a shelter); 86 (95%) patients reported staying 
in a shelter, having no ﬁ  xed address, and/or using services 
for homeless persons >1× per week. Five (5%) patients 
did not fall into any of these categories but had lived in 
a rooming house during the past year. Birthplace was 
available for 88 patients; nearly one third (n = 28; 32%) 
were born outside Canada (Table 1). The proportion of 
foreign-born patients increased over time from 24% (n = 
10) in 1998–2002 to 39% (n = 18) in 2003–2007 (Table 
2). Among the Canada-born homeless persons with TB, 
13 (22%) were Aboriginal. The number of reported cases 
of active TB over the study period by place of birth is 
shown in Figure 2. Approximately equal numbers of 
cases were reported during the 2 periods: 44 (48%) during 
1998–2002 and 47 (52%) during 2003–2007. 
Demographic information, clinical characteristics, and 
concurrent medical conditions for patients are presented 
in Tables 2 and 3. Homeless persons with TB were often 
highly contagious at the time of diagnosis, as demonstrated 
by the large proportion of patients who had cavitating 
pulmonary disease and sputum smears with numerous acid-
fast bacilli. The median duration of symptoms for persons 
with pulmonary disease before diagnosis was 2.5 months 
(interquartile range 0.6–3.1 months). Pulmonary disease 
was found in 67 (74%) patients, among whom 29 (46%) 
showed numerous acid-fast bacilli in sputum smear. The 
proportion of pulmonary TB patients with cavitary disease 
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Figure 1. Inclusion–exclusion criteria for study of active tuberculosis 
(TB) in homeless persons, Toronto, Ontario, Canada, 1998–2007.Active Tuberculosis among Homeless Persons, Toronto
increased over time from 14% (n = 5) in 1998–2002 to 32% 
(n = 11) in 2003–2007.
In terms of treatment information and outcomes, 75% 
of homeless persons with TB started treatment within 4 
days of diagnosis (median 1 day; interquartile range 0–4 
days) (Table 4). Most patients received closely monitored 
treatment within hospitals or as outpatients under directly 
observed therapy (DOT) (median treatment duration 2.0 and 
6.2 months, respectively); few received self-administered 
therapy for any substantial period of time. Only 1 patient 
required a court order for treatment in a TB sanitarium. 
Almost 1 of 5 (n = 17; 19%) patients died (from any 
cause) within 12 months of diagnosis (Table 4); most (n = 
12; 86%) patients who died were born in Canada; 4 were 
HIV positive, 1 was HIV negative, and the remaining 12 
had unknown HIV status. Among patients who survived, 
most (n = 70; 96%) homeless persons with TB successfully 
completed treatment and only 3 were lost to follow-up or 
refused further care. Probability of survival during the 12 
months after diagnosis was lower for Canada-born versus 
foreign-born homeless persons (p = 0.06; Figure 3). No 
changes in survival probabilities were seen between the 2 
periods, 1998–2002 and 2003–2007 (data not shown).
TB isolates were genotyped and tested for antimicrobial 
drug resistance (Table 5). Of the 4 strains known to circulate 
among Toronto’s homeless population (A, B, C, or D), 
isolates from ≈90% of Canada-born patients belonged to 
one of these strains, and isolates from >50% of foreign-
born patients belonged to none of them. The proportion 
of isolates not belonging to these 4 strains increased over 
time, from 14% (n = 4) during 1998–2002 to 32% (n = 12) 
during 2003–2007. Almost all (n = 84; 98%) isolates were 
susceptible to ﬁ  rst-line TB medications. Only 2 isolates 
demonstrated evidence of antimicrobial drug resistance: 
1, from a Canada-born patient, was resistant to ethambutol 
only, and 1, from a foreign-born patient, was resistant to 
isoniazid only.
Discussion
Homeless persons in our cohort received nearly all 
health care services for TB in hospital or under careful 
observation in the outpatient environment. All outpatients 
received DOT, were accompanied by public health 
staff to all clinic visits, and received intensive social 
assistance. Despite these efforts, all-cause mortality rates 
for our cohort were extremely high. Among Canada-born 
homeless persons with TB in our study, 20% died within 1 
year of their diagnosis; in comparison, among all persons 
with TB in Toronto during 1999–2002, only 7.4% died 
(17). All-cause mortality rates for homeless populations 
in general are disproportionately high; rates among men 
who use shelters in Toronto are 2–8× higher than rates 
for the general population (18). Homeless persons often 
have more concurrent medical conditions (e.g., HIV, liver 
disease), mental health conditions (e.g., schizophrenia), 
and/or dependence on substances, any of which may 
raise their risk for primary or reactivated TB, complicate 
delivery of health services, and negatively affect treatment 
outcomes.
Our ﬁ  ndings reﬂ  ect the increased rates of illness and 
death among homeless persons and suggest that urgent 
measures are needed to improve TB treatment outcomes 
for this vulnerable population. Recent research suggests 
that homeless immigrants in Toronto are in general 
healthier and possess fewer concurrent illnesses than 
Canada-born homeless persons, which may explain the 
lower prevalence of concurrent illnesses among foreign-
born TB patients and the differences in mortality rates 
according to place of birth (19). 
Homeless TB patients represent ≈3% of all TB patients 
in Toronto, of which a growing proportion are foreign-
born, likely reﬂ  ecting the changing demographics in the 
city overall and in the homeless population itself. Our 
ﬁ  ndings suggest that Canada-born patients with TB were 
more likely to be infected with strains known to circulate 
within shelters and other social networks in Toronto. In 
contrast, active TB in foreign-born patients was more likely 
to result from reactivation of latent infection with strains 
acquired overseas (20,21).
To date, drug resistance among homeless TB 
patients is rare; laboratory evidence of drug resistance 
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Table 1. Country of origin for 28 foreign-born homeless persons 
with tuberculosis, Toronto, Ontario, Canada, 1998–2007 
Country No.
Burundi 1
Chile 1
China* 1
Costa Rica  1
Ethiopia* 2
Germany   1 
Guyana 2
India* 2
Iraq 1
Ireland 2
Nepal 1
Nigeria* 1
Philippines* 1
Poland 1
Somalia 2
Tanzania* 1
Tibet 1
Turkey 1
Uganda* 2
United Kingdom  1
Yemen 1 
Former Yugoslavia  1
Zimbabwe* 2
*1 of 22 countries that account for 80% of all new of tuberculosis cases 
annually (high-burden countries). RESEARCH
was demonstrated for only 2% of homeless TB patients 
compared with 14% of all culture-positive TB patients 
in Toronto (1). Because being born outside Canada is a 
known risk factor for drug-resistant TB, the rise in foreign-
born homeless TB patients and the corresponding increase 
in heterogeneity of strain genotypes are concerning and 
may pose serious and growing threats to the homeless 
shelter system (20,22–25). The outbreaks of multidrug 
resistant TB in New York City during the 1980s and early 
1990s highlight the potential dangers of introducing drug-
resistant infections into the shelter system and call for 
increased prevention and control efforts (26).
Despite the increase in foreign-born homeless persons 
with TB over time, most homeless TB patients in our 
sample were Canada-born (68%), a substantial proportion 
of whom were of Aboriginal origin (22%). By comparison, 
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Table 2. Demographic and clinical characteristics of 91 homeless persons with tuberculosis, Toronto, Ontario, Canada, 1998–2007*
Characteristic
All persons, 
no. (%) 
Canada
born, no. (%) 
Foreign born, 
no. (%)  
p
value†
1998–2002,
no. (%)  
2003–2007,
no. (%) 
p
value‡
Median age, y (IQR)  47 (38–56)  49 (42–58)  38 (30–50)  – 45 (38–59)  48 (40–54)  –
Male sex  81 (89)  53 (88)  25 (89)  1.00 40 (91)  41 (87)  0.74
Origin  0.15
  Canada born, not Aboriginal   47 (53)  47 (78)  NA 27 (64)  20 (43) 
  Canada born, Aboriginal  13 (15)  13 (22)  NA 5 (12)  8 (17) 
  Foreign born   28 (32)  NA 28 (100)  10 (24)  18 (39) 
Case type  0.43 1.00
  New   83 (91)  53 (88)  27 (96)  40 (91)  43 (91) 
  Re-treated§   8 (9)  7 (12)  1 (4)  4 (9)  4 (9) 
Method of detection  – –
  Signs and symptoms  51 (56)  30 (50)  18 (64)  23 (52)  28 (60) 
  Contact tracing  19 (21)  16 (27)  3 (11)  11 (25)  8 (17) 
  Diagnosis while under care for  
 other  condition 
8 (9)  8 (13)  0 4 (9)  4 (9) 
  Immigration screening  6 (7)  NA 6 (21)  6 (14)  0
  Active case finding (sputum  
 screening) 
3 (3)  3 (5)  0 NA 3 (6) 
  Jail  1 (1)  1 (2)  0 0 1 (2) 
  Other¶  3 (3)  2 (3)  1 (4)  0 3 (6) 
Site(s) of infection  1.00 0.15
  Pulmonary only  67 (74)  45 (75)  21 (75)  33 (75)  34 (72) 
  Extrapulmonary only  21 (23)  13 (22)  6 (21)  8 (18)  13 (28) 
  Pulmonary and extrapulmonary  3 (3)  2 (3)  1 (4)  3 (7)  0
Chest radiograph at diagnosis#   0.08
  No abnormalities  9 (13)  7 (15)  2 (9)  0.86 7 (19)  2 (5) 
  Abnormal without cavitation  45 (65)  30 (64)  15 (68)  24 (67)  21 (62) 
  Abnormal with cavitation  15 (22)  10 (21)  5 (23)  5 (14)  11 (32) 
Self-reported symptoms  73 (80)  50 (83)  20 (71)  0.26 34 (77)  39 (83)  0.60
Median time from symptom onset to 
diagnosis, mo (IQR) 
1.9 (0.6–3.1) 1.8 (0.6–2.6) 2.6 (0.8–5.8) – 1.8 (0.6–3.1)  2.2 (0.6–3.2) –
Sputum smear results at diagnosis**  0.39 0.58
  Negative  21 (33)  12 (29)  9 (43)  12 (40)  9 (27) 
  Scarce/moderate  13 (21)  8 (20)  5 (24)  5 (17)  8 (24) 
  Numerous  29 (46)  21 (51)  7 (33)  13 (43)  16 (49) 
Method of diagnosis  0.59 0.18
  Positive culture  86 (95)  55 (92)  28 (100)  40 (91)  46 (98) 
  Positive AMTD  3 (3)  3 (5)  0 3 (7)  0
  Clinical  2 (2)  2 (3)  0 1 (2)  1 (2) 
*Birthplace information available for 88 persons. IQR, interquartile range; NA, not applicable; –, no statistical test performed; AMTD, amplified 
Mycobacterium tuberculosis direct test. 
†Probability of a significant difference between Canada-born and foreign-born persons for each variable; calculated by using the 2-sided Fisher exact test 
or F
2 test, as appropriate.  
‡Probability of a significant difference between the 2 periods for each variable; calculated by using the 2-sided Fisher exact test or F
2 test, as appropriate. 
§Public Health Agency of Canada definition: documented evidence or adequate history of previously active tuberculosis (TB) that was declared cured or 
treatment completed by current standards, AND at least 6 mo have passed since the last day of previous treatment, AND a diagnosis with a subsequent 
episode of TB that meets the active TB case definition. 
¶Includes shelter screening, routine screening at other centers, and other detection methods.  
#Results for only the 70 persons with pulmonary disease. 
**Sputum smears available for 63 patients with pulmonary disease.  Active Tuberculosis among Homeless Persons, Toronto
in 2008, only 6% of persons with active TB in Toronto 
were Canada-born (1). Although TB in Canada is primarily 
a disease of foreign-born persons (14), our results suggest 
that TB transmission persists among Canada-born inner 
city homeless populations. These ﬁ  ndings also underscore 
the need to address TB transmission within the homeless 
shelter system. Furthermore, the disproportionately high 
prevalence of Canada-born Aboriginal persons in our 
sample suggests that further efforts are needed to address 
the high incidence of TB in this population. 
Homeless TB patients tend to seek care when disease 
is advanced and highly contagious, deﬁ  ned by abnormal 
chest radiographic ﬁ   ndings (cavitation) and numerous 
acid-fast bacilli in sputum smear. Although many 
homeless patients had pulmonary disease, the number 
was proportional to the prevalence of pulmonary disease 
among all TB patients in Toronto (1). In patients with 
pulmonary TB, nearly half had numerous acid-fast bacilli 
in sputum smear. An increasing prevalence of cavitary 
disease on chest radiographs was observed over time, 
despite increasing intervention and active case-ﬁ  nding 
initiatives during the more recent 5-year period of this 
study. However, the increase in cavitary disease could 
be related to delays in seeking health care, as indicated 
by the increase in median time from symptom onset to 
diagnosis over the 2 periods of the study. 
Homeless TB patients often have difﬁ  culty accessing 
the health care system and may prioritize subsistence needs 
such as food and shelter over health services, especially 
those perceived as discretionary (27). These factors, as 
well as cultural and language barriers among foreign-born 
patients (28,29), may contribute to delays in seeking health 
care, which lead to advanced disease and hospitalization 
(27,30,31). For our sample, hospitalization rates were high; 
>80% of patients were hospitalized. This is noteworthy in 
Canada, where most TB patients are treated as outpatients, 
even at the time of diagnosis (32). The inability to isolate 
infectious homeless patients in outpatient settings such as 
shelters largely explains the high rate of hospitalization for 
patients in our sample.
Adherence to treatment is often challenging for patients 
who are homeless or living in transient, substandard 
housing and who may have concurrent substance use or 
mental health problems. Consequently, DOT is usually 
implemented for homeless persons with TB in Canada 
(32). In the province of Ontario, all patients with active 
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Figure 2. Number of reported cases of active tuberculosis in 
homeless persons, Toronto, Ontario, Canada, 1998–2007. 
Table 3. Concurrent conditions of 91 homeless persons with tuberculosis, Toronto, Ontario, Canada, 1998–2007*
Condition
All persons, 
no. (%) 
Canada
born, no. (%) 
Foreign born, 
no. (%)  
p
value†
1998–2002,
no. (%)  
2003–2007,
no. (%) 
p
value‡
HIV infection  0.52 0.33
  Positive  11 (12)  9 (15)  1 (4)  5 (11)  6 (13) 
  Negative  6 (7)  4 (7)  2 (7)  1 (2)  5 (10) 
  Unknown  74 (81)  47 (78)  25 (89)  38 (87)  36 (77) 
Psychiatric disease§  10 (11)  7 (12)  2 (7)  0.71 2 (5)  8 (17)  0.09
COPD   8 (9)  7 (12)  0 0.09 6 (14)  2 (4)  0.15
Liver disease¶  29 (32)  24 (40)  4 (14)  0.03 12 (27)  17 (36)  0.38
Cancer  5 (5)  4 (7)  1 (4)  1.00 3 (7)  2 (4)  0.67
Congestive heart failure   1 (1)  0 0 – 1 (2)  0 0.48
Diabetes 11 (12)  5 (8)  5 (18)  0.28 1 (2)  10 (21)  0.01
Chronic alcohol abuse  29 (32)  23 (38)  6 (21)  0.15 12 (27)  17 (36)  0.38
Injection drug use 12 (13)  10 (17)  1 (4)  0.16 6 (14)  6 (13)  1.00
Noninjection drug use  6 (7)  6 (10)  0 0.17 0 6 (13)  0.03
Other  1 (1)  0 1(4)  0.32 0 1 (2)  1.00
*Birthplace information available for 88 persons. –, no statistical test performed; COPD, chronic obstructive pulmonary disease.
†Probability of a significant difference between Canada-born and foreign-born persons for each variable; calculated by using the 2-sided Fisher exact test 
or F
2 test, as appropriate.  
‡Probability of a significant difference between the 2 periods for each variable; calculated by using the 2-sided Fisher exact test or F
2 test, as appropriate. 
§Includes schizophrenia, severe mental illness, and dementia. 
¶Includes cirrhosis, viral hepatitis B or C. RESEARCH
TB are eligible to receive either inpatient or outpatient TB 
treatment, regardless of their insurance coverage. Most 
patients in our sample received their entire treatment closely 
monitored within hospitals, with outpatient DOT, or both. A 
few patients self-administered treatment for short periods. 
Despite the common perception that homeless TB patients 
are noncompliant with treatment (33–35), ≈80% of patients 
in our sample completed treatment, which is equivalent to 
the treatment completion rate for all TB patients in Toronto 
receiving DOT (1). Intensive case management by public 
health and clinic staff as well as small incentives and 
enablers (e.g., food vouchers or cash) helped ensure high 
completion rates for this population. For most homeless TB 
patients who did not complete treatment, the reason was 
that they died; only a few were lost to follow-up or refused 
further care. 
The strength of this study is that it provides a 
comprehensive description of all cases of TB among 
homeless persons in a large, ethnically diverse city in 
Canada over a 10-year period. However, the study also 
has limitations. Only patients who were residents of the 
city of Toronto at the time of diagnosis were included in 
the analysis; consequently, homeless persons with active 
TB who may have been exposed in Toronto shelters or 
rooming houses and later moved elsewhere were not 
detected. Furthermore, homeless persons with TB were not 
included in the analysis if they had a history of shelter use 
>1 year before diagnosis with active TB. As a result, some 
patients who acquired TB infection while homeless but 
who subsequently acquired housing may have been missed. 
Furthermore, our retrospective study used public health 
surveillance data; consequently, our analyses are subject to 
limitations in how the data were originally collected. We 
excluded 14 patients with active TB because their records 
were incomplete; hence, we were unable to determine 
whether they differed demographically from included 
patients. This limitation could have inﬂ  uenced the results 
of our analyses that were stratiﬁ  ed by birthplace.
Molecular  ﬁ   ngerprinting data were unavailable for 
20 isolates, which may have inﬂ  uenced the genotyping 
trends we observed over time. Because we were unable 
to deﬁ  nitively determine the number of patients who died 
directly or indirectly as a result of TB, the mortality rates 
represent death from all causes in the year after TB diagnosis. 
Although our study was conducted in a single metropolitan 
urban center, our ﬁ  ndings and recommendations may be 
relevant to other large cities where levels of immigration 
and poverty are high.
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Table 4. Treatment-associated characteristics of 91 homeless persons with tuberculosis, Toronto, Ontario, Canada, 1998–2007* 
Characteristic
All persons, 
no. (%) 
Canada-born, 
no. (%)  
Foreign born, 
no. (%)   p value† 
1998–2002,
no. (%)  
2003–2007,
no. (%)  p value‡
Days from diagnosis to initiation 
of treatment, median (IQR) 
1 (0–4)  0.5 (0–4)  1 (0–6)  –  1 (0–3)  1 (0–4)  – 
Duration of treatment, mo, 
median (IQR) 
          
 Total  9.9   
(6.5–12.7) 
10.0
(6.8–12.5) 
8.6
(6.0–12.9) 
– 9.0 
(6.1–12.2) 
10.8
(6.7–13.1) 
–
  Treatment in institution  2.0
(0.2–4.0) 
2.4
(0.5–3.9) 
0.6
(0–4.2) 
 0.9 
(0.2–3.9) 
2.2
(0.0–4.1) 
  Treatment under directly  
 observed  therapy 
6.2
(0.8–8.8) 
6.4
(0.9–9.0) 
6.0
(2.4–7.2) 
 5.7 
(0.2–7.0) 
6.6
(4.5–9.0) 
  Treatment by self- 
 administered  therapy 
0.1
(0.1–0.9) 
0.1
(0.1–0.6) 
0.3
(0.1–2.1) 
 0.2 
(0.0–1.1) 
0.1
(0.1–0.6) 
Admission to hospital  76 (84)  55 (92)  19 (68)  0.01  35 (80)  41 (87)  0.40 
Treatment under public health 
order§ 
15 (16)  9 (15)  6 (21)  0.55  4 (9)  11 (23)  0.09 
Court-ordered detention for 
treatment¶ 
1 (1)  1 (2)  0 –  1 (2)  0  – 
Outcome#   0.13 0.74
  Treatment completed  70 (78)  45 (75)  25 (93)    33 (75)  37 (80)   
 Died  while  receiving 
 treatment** 
17 (19)  12 (20)  2 (7)    9 (20)  7 (16)   
  Lost to follow-up  2 (2)  2 (3)  0 1 (2)  1 (2)   
  Refused further care  1 (1)  1 (2)  0 1 (2)  0
*Birthplace information available for 88 persons. IQR, interquartile range; –, no statistical test performed. 
†Probability of a significant difference between Canada-born and foreign-born persons for each variable; calculated by using the 2-sided Fisher exact test 
or F
2 test, as appropriate.  
‡Probability of a significant difference between the 2 periods for each variable; calculated by using the 2-sided Fisher exact test or F
2 test, as appropriate. 
§Referred to in Ontario as a Section 22. 
¶Referred to in Ontario as a Section 35. 
#1 patient continues treatment at the time of this report. 
**One foreign-born case-patient from 2003–2007 period died 14 mo after onset of treatment. Study considers death from all causes within 12 mo of TB 
diagnosis. After 12 mo, causes of death other than TB become more relevant; therefore, deaths occurring after 12 mo are not included in this estimate. Active Tuberculosis among Homeless Persons, Toronto
Prior research among homeless persons in New York 
City shows decreasing trends in rates of active TB during 
1992–2006 and demonstrates that public health prevention 
and control efforts (e.g., latent TB infection screening) in 
this population can be effective (36). In our study, several 
homeless patients were originally identiﬁ  ed as tuberculin 
skin test–positive contacts before active TB developed, 
but they were unwilling to start treatment for latent TB 
infection, were deemed poor candidates for treatment 
because of serious underlying medical or mental health 
conditions, or could not complete a course of treatment 
because of adverse drug reactions. Lack of treatment 
for latent TB occurred despite substantial incentives and 
enablers for persons to initiate and continue therapy (e.g., 
cash for attending clinic visits, free passes for taxis or public 
transit, use of DOT for latent TB infection). Hence, for this 
cohort the opportunity to mitigate the risk for development 
of active TB through the treatment of latent TB infection 
was limited by the above challenges.
Primary prevention efforts should focus on shelter-
based control measures, which have proven effective at 
reducing person-to-person spread of drug-resistant TB in 
other urban centers (37). Improved ventilation systems 
at shelters will help reduce the spread of TB during an 
outbreak (38,39). Smaller shelter sizes and strategies to 
reduce mobility (e.g., eliminating length of stay restrictions 
at shelters) may also help limit the extent of transmission. 
Additionally, expansion of sustainable housing program 
for homeless and marginally housed populations will help 
reduce the number of persons needing to use shelters, 
subsequently decreasing the likelihood of TB exposure at 
these congregate settings.
Control of TB in homeless populations within Canada 
will require further progress in primary prevention (e.g., 
improved ventilation and other infection control measures 
in shelters), secondary prevention (e.g., earlier detection and 
treatment of TB infection or disease through greater access 
to primary care), and tertiary prevention (e.g., treatment of 
active TB by health care providers with experience treating 
TB in homeless persons) (17). Furthermore, Canada’s 
interconnectedness with the global community, and 
consequent interdependence with global TB, necessitates 
continued vigilance to confront the emerging threat of 
drug-resistant TB in the world (40).
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Figure 3. Probability of death from all causes during the 12-month 
period after tuberculosis diagnosis among Canada-born and 
foreign-born homeless persons with active tuberculosis, Toronto, 
Ontario, Canada, 1998–2007. Birthplace information available for 
88 persons. Censored are patients who completed treatment for 
tuberculosis or were lost to follow up.
Table 5. Characteristics of isolates from 91 homeless persons with tuberculosis, Toronto, Ontario, Canada, 1998–2007* 
Characteristic
Culture-confirmed 
case, no. (%) 
Canada-born, 
no. (%)  
Foreign born, 
no. (%)   p value† 
1998–2002,
no. (%)  
2003–2007,
no. (%)  p value‡ 
RFLP type   <0.001 0.13
  Strain A  32 (48)  25 (52)  6 (38)  17 (59)  15 (41) 
  Strain B  8 (12)  7 (15)  1 (6)  3 (10)  5 (14) 
  Strain C  7 (11)  7 (15)  0 5 (17)  2 (5) 
  Strain D  3 (5)  3 (6)  0 0 3 (8) 
  Other strain  16 (24)  6 (13)  9 (56)  4 (14)  12 (32) 
 Not  tested  20 7 12 11 9
Antimicrobial drug resistance  1.00 0.21
  No   84 (98)  54 (98)  27 (96)  38 (95)  46 (100) 
  Yes§  2 (2)  1 (2)  1 (4)  2 (5)  0
*Birthplace information available for 88 persons. RFLP, restriction fragment-length polymorphism. 
†Probability of a significant difference between Canada-born and foreign-born persons for each variable; calculated by using the 2-sided Fisher exact test 
or F
2 test, as appropriate.  
‡Probability of a significant difference between the 2 periods for each variable; calculated by using the 2-sided Fisher exact test or F
2 test, as appropriate. 
§Represents 1 Canada-born person whose isolate was resistant to ethambutol only and 1 foreign-born case whose isolate was resistant to isoniazid only. RESEARCH
Toronto. His clinical and research interests pertain to TB and other 
infectious diseases affecting immigrant and refugee populations. 
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